These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 15576658

  • 1. Intermedin/adrenomedullin-2 acts within central nervous system to elevate blood pressure and inhibit food and water intake.
    Taylor MM, Bagley SL, Samson WK.
    Am J Physiol Regul Integr Comp Physiol; 2005 Apr; 288(4):R919-27. PubMed ID: 15576658
    [Abstract] [Full Text] [Related]

  • 2. Intermedin 17-47 does not function as a full intermedin antagonist within the central nervous system or pituitary.
    White MM, Samson WK.
    Peptides; 2007 Nov; 28(11):2171-8. PubMed ID: 17945397
    [Abstract] [Full Text] [Related]

  • 3. Intermedin enhances sympathetic outflow via receptor-mediated cAMP/PKA signaling pathway in nucleus tractus solitarii of rats.
    Li P, Sun HJ, Han Y, Wang JJ, Zhang F, Tang CS, Zhou YB.
    Peptides; 2013 Sep; 47():1-6. PubMed ID: 23816795
    [Abstract] [Full Text] [Related]

  • 4. Intermedin in paraventricular nucleus attenuates sympathetic activity and blood pressure via nitric oxide in hypertensive rats.
    Zhou YB, Sun HJ, Chen D, Liu TY, Han Y, Wang JJ, Tang CS, Kang YM, Zhu GQ.
    Hypertension; 2014 Feb; 63(2):330-7. PubMed ID: 24218431
    [Abstract] [Full Text] [Related]

  • 5. Intermedin 1-53 in central nervous system elevates arterial blood pressure in rats.
    Ren YS, Yang JH, Zhang J, Pan CS, Yang J, Zhao J, Pang YZ, Tang CS, Qi YF.
    Peptides; 2006 Jan; 27(1):74-9. PubMed ID: 16023765
    [Abstract] [Full Text] [Related]

  • 6. Protective effects of intermedin on cardiovascular, pulmonary and renal diseases: comparison with adrenomedullin and CGRP.
    Holmes D, Campbell M, Harbinson M, Bell D.
    Curr Protein Pept Sci; 2013 Jun; 14(4):294-329. PubMed ID: 23745696
    [Abstract] [Full Text] [Related]

  • 7. Intermedin in the paraventricular nucleus attenuates cardiac sympathetic afferent reflex in chronic heart failure rats.
    Gan XB, Sun HJ, Chen D, Zhang LL, Zhou H, Chen LY, Zhou YB.
    PLoS One; 2014 Jun; 9(4):e94234. PubMed ID: 24709972
    [Abstract] [Full Text] [Related]

  • 8. Intermedin/adrenomedullin-2 dilates the rat pulmonary vascular bed: dependence on CGRP receptors and nitric oxide release.
    Burak Kandilci H, Gumusel B, Wasserman A, Witriol N, Lippton H.
    Peptides; 2006 Jun; 27(6):1390-6. PubMed ID: 16412533
    [Abstract] [Full Text] [Related]

  • 9. Intermedin/Adrenomedullin-2 inhibits growth hormone release from cultured, primary anterior pituitary cells.
    Taylor MM, Bagley SL, Samson WK.
    Endocrinology; 2006 Feb; 147(2):859-64. PubMed ID: 16269457
    [Abstract] [Full Text] [Related]

  • 10. Effect of calcitonin gene-related peptide (CGRP), adrenomedullin and adrenomedullin-2/intermedin on food intake in goldfish (Carassius auratus).
    Martínez-Alvarez RM, Volkoff H, Muñoz-Cueto JA, Delgado MJ.
    Peptides; 2009 Apr; 30(4):803-7. PubMed ID: 19150637
    [Abstract] [Full Text] [Related]

  • 11. Adrenomedullin 2 (AM2)/intermedin is a more potent activator of hypothalamic oxytocin-secreting neurons than AM possibly through an unidentified receptor in rats.
    Hashimoto H, Hyodo S, Kawasaki M, Shibata M, Saito T, Suzuki H, Otsubo H, Yokoyama T, Fujihara H, Higuchi T, Takei Y, Ueta Y.
    Peptides; 2007 May; 28(5):1104-12. PubMed ID: 17386959
    [Abstract] [Full Text] [Related]

  • 12. Stress hormone secretion is altered by central administration of intermedin/adrenomedullin-2.
    Taylor MM, Samson WK.
    Brain Res; 2005 May 31; 1045(1-2):199-205. PubMed ID: 15910778
    [Abstract] [Full Text] [Related]

  • 13. Effect of adrenomedullin receptor and calcitonin gene-related peptide receptor antagonists on centrally mediated adrenomedullin renal action.
    Diaz E, Israel A.
    Brain Res Bull; 2001 May 01; 55(1):29-35. PubMed ID: 11427334
    [Abstract] [Full Text] [Related]

  • 14. Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension.
    Zhao Y, Bell D, Smith LR, Zhao L, Devine AB, McHenry EM, Nicholls DP, McDermott BJ.
    J Pharmacol Exp Ther; 2006 Mar 01; 316(3):1269-81. PubMed ID: 16326922
    [Abstract] [Full Text] [Related]

  • 15. Intermedin in Paraventricular Nucleus Attenuates Sympathoexcitation and Decreases TLR4-Mediated Sympathetic Activation via Adrenomedullin Receptors in Rats with Obesity-Related Hypertension.
    Sun J, Ren XS, Kang Y, Dai HB, Ding L, Tong N, Zhu GQ, Zhou YB.
    Neurosci Bull; 2019 Feb 01; 35(1):34-46. PubMed ID: 30276527
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms involved in the regional haemodynamic effects of intermedin (adrenomedullin 2) compared with adrenomedullin in conscious rats.
    Jolly L, March JE, Kemp PA, Bennett T, Gardiner SM.
    Br J Pharmacol; 2009 Aug 01; 157(8):1502-13. PubMed ID: 19681873
    [Abstract] [Full Text] [Related]

  • 17. Calcitonin gene-related peptide-evoked sustained tachycardia in calcitonin receptor-like receptor transgenic mice is mediated by sympathetic activity.
    Kunz TH, Scott M, Ittner LM, Fischer JA, Born W, Vogel J.
    Am J Physiol Heart Circ Physiol; 2007 Oct 01; 293(4):H2155-60. PubMed ID: 17660394
    [Abstract] [Full Text] [Related]

  • 18. Adrenomedullin 2/intermedin in the hypothalamo-pituitary-adrenal axis.
    Takahashi K, Morimoto R, Hirose T, Satoh F, Totsune K.
    J Mol Neurosci; 2011 Feb 01; 43(2):182-92. PubMed ID: 20596793
    [Abstract] [Full Text] [Related]

  • 19. Adrenomedullin inhibits feeding in the rat by a mechanism involving calcitonin gene-related peptide receptors.
    Taylor GM, Meeran K, O'Shea D, Smith DM, Ghatei MA, Bloom SR.
    Endocrinology; 1996 Aug 01; 137(8):3260-4. PubMed ID: 8754748
    [Abstract] [Full Text] [Related]

  • 20. Intermedin (adrenomedullin-2): a novel counter-regulatory peptide in the cardiovascular and renal systems.
    Bell D, McDermott BJ.
    Br J Pharmacol; 2008 Mar 01; 153 Suppl 1(Suppl 1):S247-62. PubMed ID: 17965749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.